<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1885-642X</journal-id>
<journal-title><![CDATA[Pharmacy Practice (Granada)]]></journal-title>
<abbrev-journal-title><![CDATA[Pharmacy Pract (Granada)]]></abbrev-journal-title>
<issn>1885-642X</issn>
<publisher>
<publisher-name><![CDATA[Centro de Investigaciones y Publicaciones Farmacéuticas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1885-642X2021000100019</article-id>
<article-id pub-id-type="doi">10.18549/pharmpract.2021.1.2248</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Primary healthcare policy and vision for community pharmacy and pharmacists in Germany]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Eickhoff]]></surname>
<given-names><![CDATA[Christiane]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Griese-Mammen]]></surname>
<given-names><![CDATA[Nina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Müeller]]></surname>
<given-names><![CDATA[Uta]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Said]]></surname>
<given-names><![CDATA[André]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[Martin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Federal Union of German Associations of Pharmacists (ABDA) Department of Medicine Division Scientific Development]]></institution>
<addr-line><![CDATA[Berlin ]]></addr-line>
<country>Germany</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Federal Union of German Associations of Pharmacists (ABDA) Department of Medicine Division Scientific Evaluation]]></institution>
<addr-line><![CDATA[Berlin ]]></addr-line>
<country>Germany</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Federal Union of German Associations of Pharmacists (ABDA) Department of Medicine Division Scientific Development]]></institution>
<addr-line><![CDATA[Berlin ]]></addr-line>
<country>Germany</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Federal Union of German Associations of Pharmacists (ABDA) Department of Medicine Office of the Drug Commission of German Pharmacists]]></institution>
<addr-line><![CDATA[Berlin ]]></addr-line>
<country>Germany</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Federal Union of German Associations of Pharmacists (ABDA) Department of Medicine ]]></institution>
<addr-line><![CDATA[Berlin ]]></addr-line>
<country>Germany</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<volume>19</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1885-642X2021000100019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1885-642X2021000100019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1885-642X2021000100019&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Germany is the highest populated country in Europe with a population of 82.3 million in 2019. As in many other developed countries, it has an aging population. Approximately 10% of the gross domestic product is spent on healthcare. The healthcare system is characterized by its accessibility. Patients are generally free to choose their primary care physicians, both family doctors and specialists, pharmacy, dentist, or emergency service. Up to a certain income, health insurance is mandatory with the statutory health insurance (SHI) system, covering 88% of the population. Major challenges are the lack of cooperation and integration between the different sectors and healthcare providers. This is expected to change with the introduction of a telematic infrastructure that is currently being implemented. It will not only connect all providers in primary and secondary care in a secure network but will also enable access to patients&#8217; electronic record/medical data and at the same time switch from paper to electronic prescriptions. Approximately 52,000 of the 67,000 pharmacists are working in approximately 19,000 community pharmacies. These pharmacies are owner-operated by a pharmacist. Pharmacists may own up to three subsidiaries nearby to their main pharmacy. Community pharmacy practice mainly consists of dispensing drugs, counselling patients on drug therapy and safety, and giving advice on lifestyle and healthy living. Many cognitive pharmaceutical services have been developed and evaluated in the past 20 years. Discussions within the profession and with stakeholders on the national level on the roles and responsibilities of pharmacists have resulted in nationally agreed guidelines, curricula, and services. However, cognitive services remunerated by the SHI funds on the national level remain to be negotiated and sustainably implemented. A law passed in November 2020 by parliament will regulate the remuneration of pharmaceutical services by the SHI funds with an annual budget of EUR 150 million. The type of services and their remuneration remain to be negotiated in 2021. The profession has to continue on all levels to advocate for a change in pharmacy practice by introducing pharmacy services into routine care.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Pharmacies]]></kwd>
<kwd lng="en"><![CDATA[Primary Health Care]]></kwd>
<kwd lng="en"><![CDATA[Delivery of Health Care]]></kwd>
<kwd lng="en"><![CDATA[Integrated]]></kwd>
<kwd lng="en"><![CDATA[Ambulatory Care]]></kwd>
<kwd lng="en"><![CDATA[Community Health Services]]></kwd>
<kwd lng="en"><![CDATA[Pharmacists]]></kwd>
<kwd lng="en"><![CDATA[Community Pharmacy Services]]></kwd>
<kwd lng="en"><![CDATA[Professional Practice]]></kwd>
<kwd lng="en"><![CDATA[Germany]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<source><![CDATA[Federal Statistical Office]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Germany:population by age]]></article-title>
<source><![CDATA[Statista]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Busse]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ognyanova]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Blümel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[The German health care system:Stakeholders, data, analyses]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Stuttgart ]]></publisher-loc>
<publisher-name><![CDATA[Medizinisch Wissenschaftliche Verlagsgesellschaft]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Busse]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Disease management programs in Germany's statutory health insurance system]]></article-title>
<source><![CDATA[Health Aff (Millwood)]]></source>
<year>2004</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>56-67</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwabe]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Ludwig,]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
</person-group>
<source><![CDATA[Drug Report 2020]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Berlin ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kringos]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Boerma]]></surname>
<given-names><![CDATA[WGW]]></given-names>
</name>
<name>
<surname><![CDATA[Hutchinson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Saltman]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
</person-group>
<source><![CDATA[Building primary care in a changing Europe:Case studies]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Copenhagen ]]></publisher-loc>
<publisher-name><![CDATA[European Observatory on Health Systems and Policies]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schlette]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lisac]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Blum]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Integrated primary care in Germany: the road ahead]]></article-title>
<source><![CDATA[Int J Integr Care]]></source>
<year>2009</year>
<volume>9</volume>
<page-range>e14</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Knieps]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Amelung]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Wolf]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Healthcare in regions difficult to cover:Basic principles, definitions, problem analyses]]></article-title>
<source><![CDATA[GuS]]></source>
<year>2012</year>
<volume>66</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>8-19</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schulte]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Medical care centers:improving ambulatory care versus selection and exclusion of patient groups]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Baden-Baden ]]></publisher-loc>
<publisher-name><![CDATA[Nomos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eickhoff]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceutical care in community pharmacies:practice and research in Germany]]></article-title>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2006</year>
<volume>40</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>729-35</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schmiedel]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Schlager]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Dörje]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preventive counselling for public health in pharmacies in South Germany]]></article-title>
<source><![CDATA[Int J Clin Pharm]]></source>
<year>2013</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>138-44</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<collab>ABDA</collab>
<source><![CDATA[German Pharmacies:Figures Data Facts 2020]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<collab>Federal Ministry of Health</collab>
<source><![CDATA[The German healthcare system - Strong. Reliable. Proven]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amelung]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Hildebrandt]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Wolf]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Integrated care in Germany-a stony but necessary road!]]></article-title>
<source><![CDATA[Int J Integr Care]]></source>
<year>2012</year>
<volume>12</volume>
<page-range>e16</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sommer]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Dwenger]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Action plan of the Federal Ministry of Health for improvement of medication safety in Germany: An inventory]]></article-title>
<source><![CDATA[Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz]]></source>
<year>2018</year>
<volume>61</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1062-5</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Milstein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Blankart]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Health Care Strengthening Act:The next level of integrated care in Germany]]></article-title>
<source><![CDATA[Health Policy]]></source>
<year>2016</year>
<volume>120</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>445-51</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<collab>gematik</collab>
<source><![CDATA[Legal foundations:Company for telematic applications of the electronic health card]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Minister-Premiere bei der conhIT:[Jens Spahn established a department for digitalization at the German Federal Ministry of Health]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<source><![CDATA[Law for secure digital communication and applications in the health care system. E-Health act]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<source><![CDATA[Law for better care through digitalization and innovation. Digital care act]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<collab>ABDA</collab>
<source><![CDATA[Pharmacy 2030 - Perspectives on provision of pharmacy services in Germany]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rose]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Schaffert]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Czarnecki]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect evaluation of an interprofessional medication therapy management approach for multimorbid patients in primary care:a cluster-randomized controlled trial in community care (WestGem study protocol)]]></article-title>
<source><![CDATA[BMC Fam Pract]]></source>
<year>2015</year>
<volume>16</volume>
<page-range>84</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="">
<collab>Bundesapothekerkammer</collab>
<source><![CDATA[LeiKa:Catalogue of counselling and other services in pharmacies]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weissenborn]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Haefeli]]></surname>
<given-names><![CDATA[WE]]></given-names>
</name>
<name>
<surname><![CDATA[Peters-Klimm]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Seidling]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interprofessional communication between community pharmacists and general practitioners:a qualitative study]]></article-title>
<source><![CDATA[Int J Clin Pharm]]></source>
<year>2017</year>
<volume>39</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>495-506</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="">
<collab>Committee pharmacists in diabetology</collab>
<source><![CDATA[Cooperation - diabetes]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Griese-Mammen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Schumacher]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and implementation of blood pressure screening and referral guidelines for German community pharmacists]]></article-title>
<source><![CDATA[J Clin Hypertens (Greenwich)]]></source>
<year>2020</year>
<volume>22</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1807-16</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schmiedel]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Mayr]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fießler]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Schlager]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Friedland]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of the lifestyle intervention program GLICEMIA in people at risk for type 2 diabetes: a cluster-randomized controlled trial]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2015</year>
<volume>38</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>937-9</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Verheyen]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mühlig]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceutical care services for asthma patients:a controlled intervention study]]></article-title>
<source><![CDATA[J Clin Pharmacol]]></source>
<year>2001</year>
<volume>41</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>668-76</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hämmerlein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Müller]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients]]></article-title>
<source><![CDATA[J Eval Clin Pract]]></source>
<year>2011</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>61-70</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Müller]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Hämmerlein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Casper]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Community pharmacy-based intervention to improve self-monitoring of blood glucose in type 2 diabetic patients]]></article-title>
<source><![CDATA[Pharm Pract (Granada)]]></source>
<year>2006</year>
<volume>4</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>195-203</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seidling]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Send]]></surname>
<given-names><![CDATA[AFJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bittmann]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication review in German community pharmacies - Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project]]></article-title>
<source><![CDATA[Res Social Adm Pharm]]></source>
<year>2017</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1127-34</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Griese-Mammen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Anker]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacy-based interdisciplinary intervention for patients with chronic heart failure:results of the PHARM-CHF randomized controlled trial]]></article-title>
<source><![CDATA[Eur J Heart Fail]]></source>
<year>2019</year>
<volume>21</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1012-21</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="">
<source><![CDATA[National disease management guidelines]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dalhoff]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Alsdorf]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[National Asthma Care Guideline]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Berlin ]]></publisher-loc>
<publisher-name><![CDATA[AWMF]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mangiapane]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mühlig]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ihle]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Schubert]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Waldmann]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Community pharmacy-based pharmaceutical care for asthma patients]]></article-title>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2005</year>
<volume>39</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1817-22</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="">
<source><![CDATA[National disease management guideline for the treatment of type 2 diabetes]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="">
<collab>Bundesärztekammer</collab>
<source><![CDATA[National Diabetes Care Guideline:Structured training programs]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="">
<collab>Kommission Apotheker in der Diabetologie</collab>
<source><![CDATA[Consensus paper of the German Diabetes Society and the Federal Chamber of Pharmacists. Pharmaceutical care for people with diabetes and health counselling of people with a risk for diabetes:options and limitations]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="">
<collab>Bundesapothekerkammer</collab>
<source><![CDATA[Inquiry at the Regional Chambers of Pharmacists on the number of certified advances trainings conducted]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="">
<source><![CDATA[National disease management guideline chronic heart failure]]></source>
<year></year>
<edition>3</edition>
<publisher-loc><![CDATA[Berlin ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwarz]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Müller]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hauner]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Landgraf]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention of type 2 diabetes in Germany--a challenge for health professionals]]></article-title>
<source><![CDATA[Med Monatsschr Pharm]]></source>
<year>2007</year>
<volume>30</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>289-96</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwarz]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lindstrom]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tuomilehto]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tools for predicting the risk of type 2 diabetes in daily practice]]></article-title>
<source><![CDATA[Horm Metab Res]]></source>
<year>2009</year>
<volume>41</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>86-97</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="">
<source><![CDATA[Coordination group on implementing and updating the action plan for improvement of medication safety (Version 2.0, updated version)]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wenger]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality indicators for continuity and coordination of care in vulnerable elders]]></article-title>
<source><![CDATA[J Am Geriatr Soc]]></source>
<year>2007</year>
<volume>55</volume>
<numero>Suppl 2</numero>
<issue>Suppl 2</issue>
<page-range>S285-92</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuske]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lessing]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lux]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Schmitz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Schrappe]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient safety indicators for medication safety (AMTS-PSI):international status, transferability and validation]]></article-title>
<source><![CDATA[Gesundheitswesen]]></source>
<year>2012</year>
<volume>74</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>79-86</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="book">
<collab>Committee on Identifying and Preventing Medication Errors</collab>
<source><![CDATA[What can you do to avoid medication errors:fact sheet]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Washington, DC ]]></publisher-loc>
<publisher-name><![CDATA[IOM]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Botermann]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Basic preconditions for the electronic configuration of medication data with regard to the medication plan:Action plan of the Federal Ministry of Health to improve medication safety in Germany]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Müller]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mätzler]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Electronically supported co-operation of physicians and pharmacists to improve medication safety in the ambulatory setting:The &#8220;Arzneimittelinitiative Sachsen-Thüringen&#8221;(ARMIN)]]></article-title>
<source><![CDATA[Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz]]></source>
<year>2018</year>
<volume>61</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1119-28</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dormann]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Maas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Eickhoff]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Standardized national medication plan:The pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA]]></article-title>
<source><![CDATA[Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz]]></source>
<year>2018</year>
<volume>61</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1093-102</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>50</label><nlm-citation citation-type="">
<source><![CDATA[General practitioners disapprove of pharmacists administering influenza vaccinations]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B51">
<label>51</label><nlm-citation citation-type="">
<source><![CDATA[Social Code Book V - Statutory Health Insurance. §132j Regional model projects on influenza vaccinations in community pharmacies]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B52">
<label>52</label><nlm-citation citation-type="">
<collab>Bundesapothekerkammer</collab>
<source><![CDATA[Guidelines and working materials:Influenza vaccination (model projects)]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B53">
<label>53</label><nlm-citation citation-type="">
<collab>KBV - ABDA</collab>
<source><![CDATA[Future concept for drug provision:the ABDA-KBV-concept]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B54">
<label>54</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Waltering]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Schwalbe]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Hempel]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Information content of medication schedules prior to the implementation of the federal standard medication plan]]></article-title>
<source><![CDATA[Z Evid Fortbild Qual Gesundhwes]]></source>
<year>2016</year>
<volume>115-116</volume>
<page-range>24-32</page-range></nlm-citation>
</ref>
<ref id="B55">
<label>55</label><nlm-citation citation-type="">
<source><![CDATA[ARMIN Medicines Initiative Saxony-Thuringia]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B56">
<label>56</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Griese-Mammen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hersberger]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[Messerli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PCNE definition of medication review:reaching agreement]]></article-title>
<source><![CDATA[Int J Clin Pharm]]></source>
<year>2018</year>
<volume>40</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1199-208</page-range></nlm-citation>
</ref>
<ref id="B57">
<label>57</label><nlm-citation citation-type="">
<collab>Bundesapothekerkammer</collab>
<source><![CDATA[Medication review:Guideline of the Federal Chamber of Pharmacists]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B58">
<label>58</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bergert]]></surname>
<given-names><![CDATA[FW]]></given-names>
</name>
<name>
<surname><![CDATA[Braun]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ehrenthal]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[General practitioners guideline:Recommendations on the use of polymedication for adults and geriatric patients]]></source>
<year></year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
